antitrust law

(redirected from Anti-trust legislation)
Also found in: Dictionary, Thesaurus, Legal, Financial.

antitrust law

Legislation that limits the ability of an enterprise or group of individuals to monopolise a service or product, thereby controlling and restricting free trade.

antitrust law

Government Legislation that limits the ability of organizations or groups of individuals to monopolize a service–or product, thereby controlling and restricting free trade. See Safe harbor rules.
Mentioned in ?
References in periodicals archive ?
Perez Motta has in the past criticized efforts by the large conglomerates to block the anti-trust legislation.
The European Commission's long-awaited draft guidelines on a key piece of anti-trust legislation - Article 82 of the EC Treaty on abuse of dominant position - will not be circulated until next year, a Commission official confirmed at a closed meeting of EU competition lawyers in Brussels on September 23.
The wait period under anti-trust legislation in the United States expired earlier this month.
Estonia only needs to ensure that its anti-trust legislation is not in contradiction with the more recent Community block exemptions, and to provide resources to ensure effective enforcement, in view of the recent criminalisation of anti-trust offences.
discusses presidential campaign issues, Internet privacy issues and anti-trust legislation with focus on America Online Inc.
The BBC is also implicated in the investigation which, under recent changes to UK competition law (to align it more closely with EU anti-trust legislation under Article 85 of the EC Treaty) implicated both organisations of price fixing or "restrictive practice".
conducting the only legal gambling casino in the State of New York not on ancestral reservation land," and asks if such actions constitute a violation of existing anti-trust legislation.
The DAK-G assumes that this method does not fall within the scope of the anti-trust legislation due to the lack of a selection decision and the non-discriminatory accessibility of all pharmaceutical companies.